Assessment of candidemia-attributable mortality in critically ill patients using propensity score matching analysis

Abstract

Insights

ICU-acquired candidemia in critically ill patients does not increase ICU or hospital mortality. This study used propensity score matching to analyze outcomes in intensive care unit patients with candidemia.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Epidemiology

Background:

  • Candidemia in critically ill patients is a severe condition with high mortality.
  • The impact of candidemia on intensive care unit (ICU) patient outcomes and attributable mortality remains debated.
  • This study aimed to determine the attributable mortality of ICU-acquired candidemia.

Purpose of the Study:

  • To assess the attributable mortality associated with candidemia in critically ill patients.
  • To investigate the impact of ICU-acquired candidemia on patient outcomes.
  • To utilize propensity score matching for robust analysis of candidemia's effects.

Main Methods:

  • Prospective observational study in 36 ICUs across Spain, France, and Argentina.
  • Inclusion of non-neutropenic adult patients admitted for at least seven days.
  • Propensity score matching (Mahalanobis metric) and modified Poisson regression for mortality analysis.

Main Results:

  • 38 cases of candidemia in 1,107 patients (34.3 episodes/1,000 ICU patients).
  • Crude ICU mortality: 52.6% with candidemia vs. 20.6% without (P < 0.001).
  • Propensity matched analysis showed no significant difference in ICU or hospital mortality between groups.

Conclusions:

  • ICU-acquired candidemia in critically ill patients is not associated with increased ICU mortality.
  • ICU-acquired candidemia in critically ill patients is not associated with increased hospital mortality.
  • Findings suggest candidemia may not be an independent predictor of mortality in this population.